Brown Miller Wealth Management LLC Grows Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Brown Miller Wealth Management LLC grew its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 0.7% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 5,697 shares of the healthcare conglomerate’s stock after acquiring an additional 42 shares during the period. UnitedHealth Group comprises 1.5% of Brown Miller Wealth Management LLC’s investment portfolio, making the stock its 14th biggest holding. Brown Miller Wealth Management LLC’s holdings in UnitedHealth Group were worth $3,000,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in UNH. Richelieu Gestion SA purchased a new stake in UnitedHealth Group during the 4th quarter worth approximately $26,000. Robbins Farley acquired a new position in UnitedHealth Group during the 3rd quarter worth approximately $25,000. CGC Financial Services LLC grew its holdings in UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 50 shares in the last quarter. NewSquare Capital LLC grew its holdings in UnitedHealth Group by 340.0% during the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 51 shares in the last quarter. Finally, Strategic Investment Solutions Inc. IL acquired a new position in shares of UnitedHealth Group in the 1st quarter valued at $35,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In related news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several brokerages have recently issued reports on UNH. HSBC restated a “reduce” rating and issued a $480.00 target price (down previously from $550.00) on shares of UnitedHealth Group in a report on Monday, December 18th. Cantor Fitzgerald reiterated an “overweight” rating and set a $591.00 price target on shares of UnitedHealth Group in a research note on Friday, January 19th. Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Oppenheimer restated an “outperform” rating and set a $610.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, January 17th. Finally, Stephens reiterated an “overweight” rating and issued a $605.00 price target on shares of UnitedHealth Group in a report on Thursday, February 8th. One analyst has rated the stock with a sell rating, two have issued a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average price target of $579.33.

UnitedHealth Group Stock Performance

Shares of NYSE UNH traded up $1.60 during midday trading on Thursday, reaching $494.70. 3,805,551 shares of the company traded hands, compared to its average volume of 4,097,774. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.79 and a quick ratio of 0.79. The stock has a 50-day moving average price of $503.10 and a 200 day moving average price of $518.61. UnitedHealth Group Incorporated has a 52 week low of $445.68 and a 52 week high of $554.70. The company has a market cap of $456.08 billion, a price-to-earnings ratio of 20.70, a PEG ratio of 1.34 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share for the quarter, beating analysts’ consensus estimates of $5.98 by $0.18. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The company had revenue of $94.43 billion during the quarter, compared to the consensus estimate of $92.13 billion. During the same period in the prior year, the company earned $5.34 EPS. UnitedHealth Group’s revenue was up 14.1% on a year-over-year basis. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.82 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a dividend of $1.88 per share. This represents a $7.52 dividend on an annualized basis and a yield of 1.52%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is presently 31.54%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.